Marketing Authorisation For Pantoprazole Enteric-Coated Tablets In Austria
2015-04-17 16:31

The board of directors of Luye Pharma Group Ltd. (the ''Company'') is pleased to announce that the company has obtained the marketing authorisation from the Austria Federal Ministry of Health to sell Pantoprazole Enteric-coated tablets in the forms of 20mg tablets and 40mg tablets in Austria.The Company will actively seek to obtain market authorisations to sell Pantoprazole Enteric-coated tablets in other Member States within the European Union through the Multiple Recognition Procedure, using Austria as a Reference Member State.

The Company will actively promote the sale and marketing of Pantoprazole Enteric-coated tablets in overseas markets. In addition, the Company will further the registration of its key products under development (i.e. Risperidone extended release microspheres for injection, Vincristine sulphate liposome for injection and Ansofaxine hydrochloride extended release tablets) in developed countries, continue to develop overseas markets and realise the Company's globalisation strategy.

distributed by